Head-to-head · Value Score
Found vs Ro
Two GLP-1 deals, scored on the same six factors. Found lands a Value Score of 90, Ro a 74. Here's who gives you the honest lower price — and where each one bites back.
Found
#4 · Grade A · Best Value
Est. first month
$129/mo
Save ~90% vs brand-nameRo
#24 · Grade C+ · Watch List
Est. first month
Not disclosed
The verdict
Found takes it on Value Score, 90 to 74 — an est. $129/mo first month, though we flag its pricing to watch. Ro isn't out of it: Patients who want brand-name access and insurance navigation more than a visible low price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Found | Ro |
|---|---|---|
| Value Score | 90 (A) | 74 (C+) |
| Est. first month | $129/mo | Not disclosed |
| Save vs brand-name | ~90% | — |
| Semaglutide | $129/mo | Not disclosed |
| Tirzepatide | $129/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Watch | Watch |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Found
On sticker price alone, the cheapest deal here — identical $129 on both molecules, bundled into a coaching subscription.
Why it's a deal
- Cheapest disclosed price — identical $129 on both molecules
- Available in all 50 states
- Strong behavior-change coaching included
The fine print
- Price is tied to a coaching subscription you can't fully unbundle — factor the lock-in
- Compounded only
Ro
A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.
Why it's a deal
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The fine print
- Does not publish compounded pricing up front — no way to compare the deal
- Premium positioning
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.